# ACITRETIN
> **ANDA202552** · Abbreviated New Drug Application (Generic) · Sponsor: IMPAX LABS INC · Approved 2015-12-23
## Drug
- **FDA Application Number:** ANDA202552
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ACITRETIN
- **Generic name:** ACITRETIN
- **Active ingredients:** ACITRETIN
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** IMPAX LABS INC
- **Manufacturer:** Amneal Pharmaceuticals of New York LLC
- **First approval:** 2015-12-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202552)
---
*AI Analytics · CC0 1.0*